Lene Dreyer

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Merete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp et al. · Arthritis & Rheumatism · 2009 · 529 citations

Cancer risk in systemic lupus: An updated international multi-centre cohort study

Sasha Bernatsky, Rosalind Ramsey‐Goldman, Jeremy A. Labrecque et al. · Journal of Autoimmunity · 2013 · 294 citations · Full text

Epidemiology, Cancer Risk, Cancer Epidemiology +12

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti–tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

Bente Glintborg, Mikkel Østergaard, Lene Dreyer et al. · Arthritis & Rheumatism · 2010 · 243 citations

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh et al. · Annals of the Rheumatic Diseases · 2010 · 220 citations

Long‐term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis

Mikkel Faurschou, Lene Dreyer, Anne‐Lise Kamper et al. · Arthritis Care & Research · 2010 · 211 citations